Summary
For Year 2026-27, Mankind Pharma reports the following shareholding: Total Promoters at 72.66%, Mutual Fund at 10.36%, Insurance at 1.14%, Foreign Institutional Investors at 10.24%, Domestic Institutional Investors at 2.92%, and Retail at 2.68%. This breakdown provides a quick snapshot of ownership distribution for Mankind Pharma in 2026-27.
Mankind Pharma FAQs
As of 04-2026, the promoter shareholding in Mankind Pharma stands at 72.66% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Mankind Pharma is 10.24% and 2.92% respectively.
The retail shareholding of the Mankind Pharma is 2.68%.
Changes in shareholding patterns of Mankind Pharma can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Mankind Pharma are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
